nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2B6—Thiotepa—sarcoma	0.396	0.514	CbGbCtD
Perhexiline—CYP3A4—Thiotepa—sarcoma	0.122	0.158	CbGbCtD
Perhexiline—CYP2B6—Doxorubicin—sarcoma	0.0732	0.0951	CbGbCtD
Perhexiline—CYP3A4—Mitoxantrone—sarcoma	0.0523	0.0679	CbGbCtD
Perhexiline—CYP3A4—Vincristine—sarcoma	0.036	0.0467	CbGbCtD
Perhexiline—CYP2D6—Doxorubicin—sarcoma	0.0354	0.0459	CbGbCtD
Perhexiline—CYP3A4—Etoposide—sarcoma	0.033	0.0428	CbGbCtD
Perhexiline—CYP3A4—Doxorubicin—sarcoma	0.0225	0.0292	CbGbCtD
Perhexiline—Walking disability—Vincristine—sarcoma	0.0205	0.141	CcSEcCtD
Perhexiline—CPT2—myometrium—sarcoma	0.00647	0.0762	CbGeAlD
Perhexiline—CPT1A—hematopoietic system—sarcoma	0.00585	0.0689	CbGeAlD
Perhexiline—CPT2—seminal vesicle—sarcoma	0.00584	0.0688	CbGeAlD
Perhexiline—CPT1A—connective tissue—sarcoma	0.00563	0.0664	CbGeAlD
Perhexiline—CPT2—hematopoietic system—sarcoma	0.00555	0.0654	CbGeAlD
Perhexiline—CPT2—connective tissue—sarcoma	0.00535	0.063	CbGeAlD
Perhexiline—CPT2—skin of body—sarcoma	0.00483	0.0569	CbGeAlD
Perhexiline—CPT2—cardiac atrium—sarcoma	0.00422	0.0497	CbGeAlD
Perhexiline—CPT2—uterus—sarcoma	0.00419	0.0494	CbGeAlD
Perhexiline—CPT1A—tendon—sarcoma	0.00387	0.0456	CbGeAlD
Perhexiline—Cachexia—Epirubicin—sarcoma	0.00375	0.0258	CcSEcCtD
Perhexiline—CPT2—tendon—sarcoma	0.00367	0.0433	CbGeAlD
Perhexiline—CPT2—bone marrow—sarcoma	0.00356	0.0419	CbGeAlD
Perhexiline—Extrapyramidal disorder—Thiotepa—sarcoma	0.00353	0.0243	CcSEcCtD
Perhexiline—Cachexia—Doxorubicin—sarcoma	0.00347	0.0239	CcSEcCtD
Perhexiline—Polyneuropathy—Epirubicin—sarcoma	0.00329	0.0226	CcSEcCtD
Perhexiline—CPT1A—testis—sarcoma	0.00321	0.0378	CbGeAlD
Perhexiline—Optic neuritis—Etoposide—sarcoma	0.00311	0.0214	CcSEcCtD
Perhexiline—CPT2—testis—sarcoma	0.00304	0.0359	CbGeAlD
Perhexiline—Polyneuropathy—Doxorubicin—sarcoma	0.00304	0.0209	CcSEcCtD
Perhexiline—CPT1A—liver—sarcoma	0.00303	0.0357	CbGeAlD
Perhexiline—CPT2—liver—sarcoma	0.00288	0.0339	CbGeAlD
Perhexiline—Gait disturbance—Vincristine—sarcoma	0.00242	0.0166	CcSEcCtD
Perhexiline—CPT1A—lymph node—sarcoma	0.00232	0.0274	CbGeAlD
Perhexiline—CPT2—lymph node—sarcoma	0.00221	0.026	CbGeAlD
Perhexiline—Ataxia—Thiotepa—sarcoma	0.00182	0.0125	CcSEcCtD
Perhexiline—Optic neuritis—Epirubicin—sarcoma	0.00174	0.012	CcSEcCtD
Perhexiline—Optic neuritis—Doxorubicin—sarcoma	0.00161	0.0111	CcSEcCtD
Perhexiline—Ataxia—Vincristine—sarcoma	0.00161	0.0111	CcSEcCtD
Perhexiline—Muscular weakness—Vincristine—sarcoma	0.00151	0.0104	CcSEcCtD
Perhexiline—CYP2B6—hematopoietic system—sarcoma	0.00144	0.017	CbGeAlD
Perhexiline—Weight decreased—Vincristine—sarcoma	0.00134	0.00922	CcSEcCtD
Perhexiline—Hepatitis—Dactinomycin—sarcoma	0.00133	0.00913	CcSEcCtD
Perhexiline—Weight decreased—Mitoxantrone—sarcoma	0.0013	0.00898	CcSEcCtD
Perhexiline—Neuropathy peripheral—Vincristine—sarcoma	0.00129	0.0089	CcSEcCtD
Perhexiline—Liver injury—Epirubicin—sarcoma	0.00127	0.00876	CcSEcCtD
Perhexiline—Sweating—Vincristine—sarcoma	0.00126	0.00871	CcSEcCtD
Perhexiline—CYP2B6—skin of body—sarcoma	0.00126	0.0148	CbGeAlD
Perhexiline—Sweating—Mitoxantrone—sarcoma	0.00123	0.00848	CcSEcCtD
Perhexiline—Flushing—Dactinomycin—sarcoma	0.00123	0.00847	CcSEcCtD
Perhexiline—Liver injury—Doxorubicin—sarcoma	0.00118	0.00811	CcSEcCtD
Perhexiline—Hepatitis—Mitoxantrone—sarcoma	0.00115	0.00794	CcSEcCtD
Perhexiline—Tension—Thiotepa—sarcoma	0.00114	0.00786	CcSEcCtD
Perhexiline—Nervousness—Thiotepa—sarcoma	0.00113	0.00777	CcSEcCtD
Perhexiline—Gait disturbance—Epirubicin—sarcoma	0.0011	0.00755	CcSEcCtD
Perhexiline—CYP3A4—hematopoietic system—sarcoma	0.00109	0.0129	CbGeAlD
Perhexiline—CYP2D6—hematopoietic system—sarcoma	0.00107	0.0127	CbGeAlD
Perhexiline—Hepatocellular injury—Epirubicin—sarcoma	0.00107	0.00737	CcSEcCtD
Perhexiline—Neuropathy peripheral—Etoposide—sarcoma	0.00105	0.00721	CcSEcCtD
Perhexiline—CYP2B6—lymphoid tissue—sarcoma	0.00102	0.012	CbGeAlD
Perhexiline—Gait disturbance—Doxorubicin—sarcoma	0.00102	0.00699	CcSEcCtD
Perhexiline—Convulsion—Thiotepa—sarcoma	0.00101	0.00694	CcSEcCtD
Perhexiline—Hepatocellular injury—Doxorubicin—sarcoma	0.000991	0.00682	CcSEcCtD
Perhexiline—Anorexia—Thiotepa—sarcoma	0.000904	0.00623	CcSEcCtD
Perhexiline—Anorexia—Dactinomycin—sarcoma	0.000898	0.00618	CcSEcCtD
Perhexiline—Convulsion—Vincristine—sarcoma	0.000893	0.00615	CcSEcCtD
Perhexiline—Flushing—Etoposide—sarcoma	0.00089	0.00613	CcSEcCtD
Perhexiline—Convulsion—Mitoxantrone—sarcoma	0.00087	0.00599	CcSEcCtD
Perhexiline—Paraesthesia—Thiotepa—sarcoma	0.000852	0.00587	CcSEcCtD
Perhexiline—Decreased appetite—Thiotepa—sarcoma	0.000825	0.00568	CcSEcCtD
Perhexiline—Decreased appetite—Dactinomycin—sarcoma	0.000819	0.00564	CcSEcCtD
Perhexiline—Fatigue—Thiotepa—sarcoma	0.000818	0.00563	CcSEcCtD
Perhexiline—Hyperhidrosis—Vincristine—sarcoma	0.000813	0.0056	CcSEcCtD
Perhexiline—Fatigue—Dactinomycin—sarcoma	0.000812	0.00559	CcSEcCtD
Perhexiline—Shock—Mitoxantrone—sarcoma	0.000806	0.00555	CcSEcCtD
Perhexiline—Anorexia—Vincristine—sarcoma	0.000802	0.00552	CcSEcCtD
Perhexiline—Hypoglycaemia—Epirubicin—sarcoma	0.000796	0.00548	CcSEcCtD
Perhexiline—Hyperhidrosis—Mitoxantrone—sarcoma	0.000792	0.00545	CcSEcCtD
Perhexiline—CYP2B6—testis—sarcoma	0.000792	0.00933	CbGeAlD
Perhexiline—Anorexia—Mitoxantrone—sarcoma	0.000781	0.00538	CcSEcCtD
Perhexiline—Diplopia—Epirubicin—sarcoma	0.000777	0.00535	CcSEcCtD
Perhexiline—Gastrointestinal pain—Thiotepa—sarcoma	0.000776	0.00534	CcSEcCtD
Perhexiline—Gastrointestinal pain—Dactinomycin—sarcoma	0.00077	0.0053	CcSEcCtD
Perhexiline—Insomnia—Vincristine—sarcoma	0.000761	0.00524	CcSEcCtD
Perhexiline—Paraesthesia—Vincristine—sarcoma	0.000755	0.0052	CcSEcCtD
Perhexiline—Urticaria—Thiotepa—sarcoma	0.000754	0.00519	CcSEcCtD
Perhexiline—Abdominal pain—Thiotepa—sarcoma	0.00075	0.00516	CcSEcCtD
Perhexiline—CYP2B6—liver—sarcoma	0.000749	0.00882	CbGeAlD
Perhexiline—Abdominal pain—Dactinomycin—sarcoma	0.000744	0.00513	CcSEcCtD
Perhexiline—Hypoglycaemia—Doxorubicin—sarcoma	0.000737	0.00507	CcSEcCtD
Perhexiline—Paraesthesia—Mitoxantrone—sarcoma	0.000736	0.00507	CcSEcCtD
Perhexiline—Loss of consciousness—Etoposide—sarcoma	0.000734	0.00505	CcSEcCtD
Perhexiline—Decreased appetite—Vincristine—sarcoma	0.000731	0.00504	CcSEcCtD
Perhexiline—Ataxia—Epirubicin—sarcoma	0.000731	0.00503	CcSEcCtD
Perhexiline—Fatigue—Vincristine—sarcoma	0.000725	0.00499	CcSEcCtD
Perhexiline—Convulsion—Etoposide—sarcoma	0.000724	0.00498	CcSEcCtD
Perhexiline—Diplopia—Doxorubicin—sarcoma	0.000719	0.00495	CcSEcCtD
Perhexiline—Decreased appetite—Mitoxantrone—sarcoma	0.000712	0.0049	CcSEcCtD
Perhexiline—Fatigue—Mitoxantrone—sarcoma	0.000706	0.00486	CcSEcCtD
Perhexiline—Gastrointestinal pain—Vincristine—sarcoma	0.000688	0.00474	CcSEcCtD
Perhexiline—Muscular weakness—Epirubicin—sarcoma	0.000686	0.00472	CcSEcCtD
Perhexiline—Asthenia—Thiotepa—sarcoma	0.000681	0.00469	CcSEcCtD
Perhexiline—Ataxia—Doxorubicin—sarcoma	0.000676	0.00466	CcSEcCtD
Perhexiline—Asthenia—Dactinomycin—sarcoma	0.000676	0.00465	CcSEcCtD
Perhexiline—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00067	0.00461	CcSEcCtD
Perhexiline—Abdominal pain—Vincristine—sarcoma	0.000665	0.00458	CcSEcCtD
Perhexiline—Hyperhidrosis—Etoposide—sarcoma	0.000659	0.00454	CcSEcCtD
Perhexiline—Urticaria—Mitoxantrone—sarcoma	0.000651	0.00448	CcSEcCtD
Perhexiline—Anorexia—Etoposide—sarcoma	0.00065	0.00447	CcSEcCtD
Perhexiline—Abdominal pain—Mitoxantrone—sarcoma	0.000648	0.00446	CcSEcCtD
Perhexiline—Muscular weakness—Doxorubicin—sarcoma	0.000634	0.00437	CcSEcCtD
Perhexiline—Dizziness—Thiotepa—sarcoma	0.000627	0.00432	CcSEcCtD
Perhexiline—Paraesthesia—Etoposide—sarcoma	0.000612	0.00421	CcSEcCtD
Perhexiline—Weight decreased—Epirubicin—sarcoma	0.000608	0.00419	CcSEcCtD
Perhexiline—Asthenia—Vincristine—sarcoma	0.000604	0.00416	CcSEcCtD
Perhexiline—Vomiting—Thiotepa—sarcoma	0.000603	0.00415	CcSEcCtD
Perhexiline—Vomiting—Dactinomycin—sarcoma	0.000599	0.00412	CcSEcCtD
Perhexiline—Rash—Thiotepa—sarcoma	0.000598	0.00412	CcSEcCtD
Perhexiline—Dermatitis—Thiotepa—sarcoma	0.000598	0.00412	CcSEcCtD
Perhexiline—Headache—Thiotepa—sarcoma	0.000594	0.00409	CcSEcCtD
Perhexiline—Rash—Dactinomycin—sarcoma	0.000594	0.00409	CcSEcCtD
Perhexiline—Decreased appetite—Etoposide—sarcoma	0.000592	0.00408	CcSEcCtD
Perhexiline—CYP2D6—testis—sarcoma	0.000588	0.00693	CbGeAlD
Perhexiline—Asthenia—Mitoxantrone—sarcoma	0.000588	0.00405	CcSEcCtD
Perhexiline—Fatigue—Etoposide—sarcoma	0.000588	0.00405	CcSEcCtD
Perhexiline—Neuropathy peripheral—Epirubicin—sarcoma	0.000587	0.00404	CcSEcCtD
Perhexiline—Sweating—Epirubicin—sarcoma	0.000574	0.00395	CcSEcCtD
Perhexiline—CYP3A4—liver—sarcoma	0.000565	0.00666	CbGeAlD
Perhexiline—Nausea—Thiotepa—sarcoma	0.000564	0.00388	CcSEcCtD
Perhexiline—Weight decreased—Doxorubicin—sarcoma	0.000562	0.00387	CcSEcCtD
Perhexiline—Nausea—Dactinomycin—sarcoma	0.000559	0.00385	CcSEcCtD
Perhexiline—Gastrointestinal pain—Etoposide—sarcoma	0.000557	0.00384	CcSEcCtD
Perhexiline—Dizziness—Vincristine—sarcoma	0.000556	0.00383	CcSEcCtD
Perhexiline—CYP2D6—liver—sarcoma	0.000556	0.00656	CbGeAlD
Perhexiline—Neuropathy peripheral—Doxorubicin—sarcoma	0.000543	0.00374	CcSEcCtD
Perhexiline—Urticaria—Etoposide—sarcoma	0.000541	0.00373	CcSEcCtD
Perhexiline—Abdominal pain—Etoposide—sarcoma	0.000539	0.00371	CcSEcCtD
Perhexiline—Hepatitis—Epirubicin—sarcoma	0.000538	0.0037	CcSEcCtD
Perhexiline—Vomiting—Vincristine—sarcoma	0.000535	0.00368	CcSEcCtD
Perhexiline—Sweating—Doxorubicin—sarcoma	0.000531	0.00366	CcSEcCtD
Perhexiline—Rash—Vincristine—sarcoma	0.00053	0.00365	CcSEcCtD
Perhexiline—Dermatitis—Vincristine—sarcoma	0.00053	0.00365	CcSEcCtD
Perhexiline—Headache—Vincristine—sarcoma	0.000527	0.00363	CcSEcCtD
Perhexiline—Vomiting—Mitoxantrone—sarcoma	0.000521	0.00359	CcSEcCtD
Perhexiline—Rash—Mitoxantrone—sarcoma	0.000517	0.00356	CcSEcCtD
Perhexiline—Dermatitis—Mitoxantrone—sarcoma	0.000516	0.00355	CcSEcCtD
Perhexiline—Headache—Mitoxantrone—sarcoma	0.000513	0.00353	CcSEcCtD
Perhexiline—Nausea—Vincristine—sarcoma	0.0005	0.00344	CcSEcCtD
Perhexiline—Flushing—Epirubicin—sarcoma	0.000499	0.00344	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—sarcoma	0.000498	0.00343	CcSEcCtD
Perhexiline—Asthenia—Etoposide—sarcoma	0.000489	0.00337	CcSEcCtD
Perhexiline—Nausea—Mitoxantrone—sarcoma	0.000487	0.00335	CcSEcCtD
Perhexiline—Flushing—Doxorubicin—sarcoma	0.000462	0.00318	CcSEcCtD
Perhexiline—Tension—Epirubicin—sarcoma	0.000459	0.00316	CcSEcCtD
Perhexiline—Nervousness—Epirubicin—sarcoma	0.000455	0.00313	CcSEcCtD
Perhexiline—Dizziness—Etoposide—sarcoma	0.000451	0.0031	CcSEcCtD
Perhexiline—Vomiting—Etoposide—sarcoma	0.000433	0.00298	CcSEcCtD
Perhexiline—Rash—Etoposide—sarcoma	0.00043	0.00296	CcSEcCtD
Perhexiline—Dermatitis—Etoposide—sarcoma	0.000429	0.00296	CcSEcCtD
Perhexiline—Headache—Etoposide—sarcoma	0.000427	0.00294	CcSEcCtD
Perhexiline—Tension—Doxorubicin—sarcoma	0.000425	0.00293	CcSEcCtD
Perhexiline—Nervousness—Doxorubicin—sarcoma	0.000421	0.0029	CcSEcCtD
Perhexiline—Syncope—Epirubicin—sarcoma	0.00042	0.00289	CcSEcCtD
Perhexiline—Loss of consciousness—Epirubicin—sarcoma	0.000411	0.00283	CcSEcCtD
Perhexiline—Convulsion—Epirubicin—sarcoma	0.000406	0.00279	CcSEcCtD
Perhexiline—Nausea—Etoposide—sarcoma	0.000405	0.00279	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—sarcoma	0.000388	0.00267	CcSEcCtD
Perhexiline—Loss of consciousness—Doxorubicin—sarcoma	0.000381	0.00262	CcSEcCtD
Perhexiline—Shock—Epirubicin—sarcoma	0.000376	0.00259	CcSEcCtD
Perhexiline—Convulsion—Doxorubicin—sarcoma	0.000375	0.00258	CcSEcCtD
Perhexiline—Hyperhidrosis—Epirubicin—sarcoma	0.000369	0.00254	CcSEcCtD
Perhexiline—Anorexia—Epirubicin—sarcoma	0.000364	0.00251	CcSEcCtD
Perhexiline—Shock—Doxorubicin—sarcoma	0.000348	0.00239	CcSEcCtD
Perhexiline—Insomnia—Epirubicin—sarcoma	0.000346	0.00238	CcSEcCtD
Perhexiline—Paraesthesia—Epirubicin—sarcoma	0.000343	0.00236	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—sarcoma	0.000342	0.00235	CcSEcCtD
Perhexiline—Anorexia—Doxorubicin—sarcoma	0.000337	0.00232	CcSEcCtD
Perhexiline—Decreased appetite—Epirubicin—sarcoma	0.000332	0.00229	CcSEcCtD
Perhexiline—Fatigue—Epirubicin—sarcoma	0.000329	0.00227	CcSEcCtD
Perhexiline—Insomnia—Doxorubicin—sarcoma	0.00032	0.0022	CcSEcCtD
Perhexiline—Paraesthesia—Doxorubicin—sarcoma	0.000317	0.00219	CcSEcCtD
Perhexiline—Gastrointestinal pain—Epirubicin—sarcoma	0.000312	0.00215	CcSEcCtD
Perhexiline—Decreased appetite—Doxorubicin—sarcoma	0.000307	0.00212	CcSEcCtD
Perhexiline—Fatigue—Doxorubicin—sarcoma	0.000305	0.0021	CcSEcCtD
Perhexiline—Urticaria—Epirubicin—sarcoma	0.000304	0.00209	CcSEcCtD
Perhexiline—Abdominal pain—Epirubicin—sarcoma	0.000302	0.00208	CcSEcCtD
Perhexiline—Gastrointestinal pain—Doxorubicin—sarcoma	0.000289	0.00199	CcSEcCtD
Perhexiline—Urticaria—Doxorubicin—sarcoma	0.000281	0.00193	CcSEcCtD
Perhexiline—Abdominal pain—Doxorubicin—sarcoma	0.000279	0.00192	CcSEcCtD
Perhexiline—Asthenia—Epirubicin—sarcoma	0.000274	0.00189	CcSEcCtD
Perhexiline—Asthenia—Doxorubicin—sarcoma	0.000254	0.00175	CcSEcCtD
Perhexiline—Dizziness—Epirubicin—sarcoma	0.000253	0.00174	CcSEcCtD
Perhexiline—Vomiting—Epirubicin—sarcoma	0.000243	0.00167	CcSEcCtD
Perhexiline—Rash—Epirubicin—sarcoma	0.000241	0.00166	CcSEcCtD
Perhexiline—Dermatitis—Epirubicin—sarcoma	0.000241	0.00166	CcSEcCtD
Perhexiline—Headache—Epirubicin—sarcoma	0.000239	0.00165	CcSEcCtD
Perhexiline—Dizziness—Doxorubicin—sarcoma	0.000234	0.00161	CcSEcCtD
Perhexiline—Nausea—Epirubicin—sarcoma	0.000227	0.00156	CcSEcCtD
Perhexiline—Vomiting—Doxorubicin—sarcoma	0.000225	0.00155	CcSEcCtD
Perhexiline—Rash—Doxorubicin—sarcoma	0.000223	0.00153	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—sarcoma	0.000223	0.00153	CcSEcCtD
Perhexiline—Headache—Doxorubicin—sarcoma	0.000221	0.00152	CcSEcCtD
Perhexiline—Nausea—Doxorubicin—sarcoma	0.00021	0.00145	CcSEcCtD
